Pharmaceuticals & Biotechnology (4570)

28,627.08
   
  • 52 Week High: 28,699.87
  • 52 Week Low: 18,687.04

Latest ShareCast News

Shore Capital lowers AstraZeneca to 'hold'

By Iain Gilbert

Date: Friday 13 Feb 2026

(Sharecast News) - Shore Capital downgraded drugmaker AstraZeneca from 'buy' to 'hold' on Friday, stating the drugmaker's near‑term earnings outlook looked less favourable despite what it called "exceptional" R&D delivery.

Pharmaceuticals & Biotechnology Regulatory News

Result of AGM 13-Feb-2026 16:31 RNS
Form 8.3 - Oxford Biomedica plc 13-Feb-2026 15:20 RNS
Further CEO Share Purchase 13-Feb-2026 14:30 RNS
Director/PDMR Shareholding 13-Feb-2026 08:01 RNS
Form 8.5 (EPT/RI) - Oxford Biomedica plc 13-Feb-2026 07:36 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

 

Price Data

Price 28,627.08
Closing Price Change 355.28
% Change 1.26 %
13-Feb-26 Close 28,627.08

Top Risers

Price Change
SCLP 14.00p +12.0%
IMM 6.99p +7.9%
OXB 823.00p +4.2%
AGY 10.80p +2.9%
SAR 18.50p +2.8%
ONT 136.00p +2.3%
RENX 4.13p +1.9%
IXI 8.88p +1.4%
AZN 15,118.00p +1.4%
GSK 2,165.00p +1.1%

Top Fallers

Price Change
SBTX 12.38p -36.5%
CIZ 1.35p -12.9%
TLM 12.00p -7.7%
OPTI 6.30p -6.7%
NFX 0.26p -3.8%
EAH 108.00p -3.6%
GENF 1.85p -2.6%
FUM 1.30p -2.1%
AREC 72.50p -2.0%
4BB 565.00p -1.7%

Top of Page